| Financial Year |
March 31 2023 |
| Monetary Funds |
98,414,140.58 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
58,915,886.75 |
| Advances to Suppliers |
28,641,456.90 |
| Other Receivables |
5,555,774.34 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
186,658.20 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
953,502.58 |
| Total Current Assets |
192,667,419.35 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
60,579,610.47 |
| Investment Properties |
142,887,638.22 |
| Fixed Assetes |
6,991,543.80 |
| Under-construction Projects |
3,932,718.33 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
3,337,574.58 |
| R&D expenses |
-- |
| Goodwill |
631,400.11 |
| Long-Term Deferred and Prepaid Expenses |
1,186,119.39 |
| Deferred Income Tax Assets |
-- |
| Other Non-Current Assets |
4,899,851.80 |
| Sub-Total of Non-Current Assets |
796,956,619.29 |
| Total Assets |
989,624,038.64 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
33,908,695.68 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
34,207,804.38 |
| Taxes Payable |
2,080,591.15 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
21,128,394.01 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
88,257.78 |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
197,594,870.03 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
1,706,306.62 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
74,352,105.62 |
| Total Liabilities |
271,946,975.65 |
| Paid-In Capital(Or Share Stock) |
132,556,270.00 |
| Capital Surplus |
199,948,957.53 |
| Surplus Reserve |
147,798,842.16 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
217,310,611.96 |
| Minority Stockholder's Interest |
-6,348,726.66 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
724,025,789.65 |
| Owner's Equity（Stockholder's Equity） |
717,677,062.99 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
989,624,038.64 |
